-
HDFC Bank
743.25 726.75(%) -
CIE Automotive
411.35 382.20(%) -
Oracle Fin.Serv.
9,950.00 6,232.20(%) -
Bluestone Jewel
732.05 400.40(%) -
Bharti Airtel
1,925.60 1,745.00(%) -
Reliance Industries
1,268.00 1,253.65(%) -
Bajaj Finance
1,037.00 788.40(%) -
Bajaj Finserv
1,900.15 2,194.65(%) -
Tanla Platforms
656.70 765.75(%) -
Maruti Suzuki
13,371.65 12,202.10(%) -
Gandhar Oil Ref.
283.85 245.00(%) -
Route Mobile
649.90 949.80(%) -
Eternal
296.15 368.40(%) -
Adani Green
1,372.70 767.00(%) -
Infosys
1,032.30 984.00(%) -
IndusInd Bank
999.00 710.85(%) -
SBI
1,006.50 786.55(%) -
Axis Bank
1,219.05 1,041.30(%) -
CG Power & Ind
881.00 525.50(%) -
SBI Funds Mgt.
575.35 582.55(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Solara Active Pharma Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 70281.0
- ISIN : INE624Z01016
-
Today’s Low
515.70 -
Today’s High
562.00
-
Open
562.00 -
Perv Close
558.80 -
52W Low
422.00 -
52W High
734.40
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
2,561.94
-
Div & Yield %
0.00
-
Book Value(₹)
263.42
-
Debt-Equity Ratio
-4.05
-
AGM Date
22-Jul-2026
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
0.83
-
Mar.Cap (₹Cr.)
2,561.94
-
RONW (%)
0.00
-
ROCE (%)
0.00
Score Board
-
Equity (₹ in Cr.)
47.78
-
BV (₹)
263.40
-
Sales( ₹ in Cr.)
1,368.98
-
NP (in Cr.)
-1.35
-
NP Var(%)
-25.0
-
Div%
0.0
-
CPS (₹)
20.60
-
EPS (₹)
-0.30
-
Traded Value (₹ in Lakhs)
2,558.60
-
52 Week High
734.40
-
52 Week Low
422.00
-
Price BSE
535.0
-
Price NSE
536.00
-
Market Capital( in Cr.)
2,558.60
-
P/C Ratio
26.00
-
P/E Ratio
-1,893.70
-
Price Vs.BV
-0.30
-
23-Jul-2026( 02:02)
Corporate News - Solar... - Solara Active Pharma Sciences...
-
23-Jul-2026( 02:09)
Results - Announcements - Solar... - Net profit of Solara Active Ph...
-
17-Jul-2026( 10:18)
Corporate News - Solar... - Solara Active Pharma Sciences...
-
24-Jun-2026( 01:02)
Hot Pursuit - Crisi... - <P> Crisil Ratings stated that...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 1,283.76 | 1,288.92 | 1,443.81 | 1,268.34 | 1,616.88 | 1,321.75 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,283.76 | 1,288.92 | 1,443.81 | 1,268.34 | 1,616.88 | 1,321.75 |
| Other Income | 9.14 | 5.37 | 22.14 | 18.76 | 28.41 | 27.51 |
| Stock Adjustments | -39.00 | -39.27 | -7.05 | 258.75 | 2.15 | 54.16 |
| Total Income | 1,253.90 | 1,255.02 | 1,458.90 | 1,545.85 | 1,647.44 | 1,403.42 |
| EXPENDITURE : | ||||||
| Raw Materials | 587.41 | 765.75 | 781.78 | 912.64 | 726.56 | 653.03 |
| Power and Fuel Cost | 94.37 | 122.56 | 107.95 | 93.70 | 85.42 | 77.68 |
| Employee Cost | 214.75 | 246.57 | 228.05 | 234.20 | 227.63 | 202.24 |
| Other Manufacturing Expenses | 67.80 | 109.31 | 90.76 | 97.87 | 91.19 | 89.50 |
| Selling and Administration Expenses | 58.68 | 70.40 | 67.50 | 76.39 | 76.07 | 74.19 |
| Miscellaneous Expenses | 20.98 | 222.41 | 26.68 | 35.43 | 26.83 | 22.74 |
| Employee Benefit Expenses | 214.75 | 246.57 | 228.05 | 234.20 | 227.63 | 202.24 |
| Less: Preoperative Expenditure | 3.07 | 2.65 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1,040.92 | 1,534.35 | 1,302.72 | 1,450.23 | 1,233.70 | 1,119.38 |
| Operating Profit | 212.98 | -279.33 | 156.18 | 95.62 | 413.74 | 284.04 |
| Interest | 114.81 | 105.97 | 90.06 | 75.27 | 84.47 | 77.88 |
| Gross Profit | 98.17 | -385.30 | 66.12 | 20.35 | 329.27 | 206.16 |
| Depreciation | 99.25 | 103.03 | 110.90 | 112.01 | 108.31 | 93.67 |
| Profit Before Tax | -1.08 | -488.33 | -44.78 | -91.66 | 220.96 | 112.49 |
| Current Tax | 0.00 | 0.00 | -0.11 | 0.00 | 38.64 | 20.69 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 78.54 | -22.46 | -33.10 | -38.64 | -20.69 |
| Reported Net Profit | -1.08 | -566.87 | -22.21 | -58.56 | 220.96 | 112.49 |
| Extraordinary Items | 0.00 | -158.84 | -0.45 | -4.26 | 1.65 | -0.26 |
| Adjusted Net Profit | -1.08 | -408.03 | -21.76 | -54.30 | 219.31 | 112.75 |
| Adjustment below Net Profit | 1.06 | 0.56 | -1.76 | 2.01 | -2.53 | -3.85 |
| P & L Balance brought forward | -316.27 | 250.04 | 274.01 | 341.34 | 142.65 | 49.67 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 10.78 | 19.74 | 15.66 |
| P & L Balance carried down | -316.29 | -316.27 | 250.04 | 274.01 | 341.34 | 142.65 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 30.00 | 0.00 | 70.00 | 20.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 3.00 | 0.00 | 7.00 | 2.00 |
| Earnings Per Share-Unit Curr | -0.27 | -157.46 | -6.17 | -16.27 | 61.50 | 41.90 |
| Earnings Per Share(Adj)-Unit Curr | -0.27 | -145.12 | -5.69 | -15.00 | 56.68 | 38.62 |
| Book Value | 272.35 | 260.39 | 417.54 | 424.18 | 443.30 | 370.50 |
| Book Value(Adj)-Unit Curr | 272.35 | 239.98 | 384.83 | 390.94 | 408.56 | 341.46 |
